Table 1.
Demographic data.
| HAd (n=14) | HEld (n=15) | EnAd (n=18) | EnEld (n=31) | P | |
|---|---|---|---|---|---|
| Age (years) | 26±2 | 79±7a | 36±7b,d | 65±3c,e,f | <0.001 |
| Gender (Male) n (%) | 5 (36) | 1 (7) | 7 (39)d | 18 (58)e | 0.01 |
| BMI (Kg/m2) | --- | --- | 24(22.4-25.6) | 25(22.8-27.2) | 0.206# |
| Comorbidities | |||||
| SAH n (%) | 0 | 0 | 16 (89)b,d | 31 (100)e | <0.001 |
| Diabetes mellitus n (%) | 0 | 0 | 3 (17) | 15 (48)c,e | <0.001 |
| Glomerulopathy n (%) | 0 | 0 | 3 (17) | 2 (7) | 0.107 |
| ADPKD n (%) | 0 | 0 | 1 (6) | 2 (7) | 0.41 |
| Renal replacement data | |||||
| Time on RRT (months) | --- | --- | 32 (14-45.5) | 36 (21-54) | 0.23# |
| RRT (HD) n (%) | --- | --- | 17 (94) | 28 (90) | 1.0# |
| Laboratorial data | |||||
| Albumin | --- | --- | 4.4(4.17-4.62) | 4.3(3.6-4.7) | 0.4# |
| Hemoglobin | --- | --- | 12.2(9.9-13.1) | 12.6(11-12.9) | 0.88# |
| PTH | --- | --- | 236(80.5-608) | 237(130-574) | 0.868# |
HAd - healthy adults; HEld - healthy elderly; EnAd - end stage renal disease adult patients; EnEld - end stage renal disease elderly patients, BMI - body mass index, SAH - systemic arterial hypertension, ADPKD - Autosomal dominant polycystic kidney disease, RRT - renal replacement therapy, HD - hemodialysis, PTH - parathyroid hormone.
#
Comparison of EnAd and EnEld only
a
Significant difference between: aHAd and HEld;
b
HAd and EnAd;
c
HAd and EnEld;
d
HEld and EnAd;
e
HEld and EnEld;
f
EnAd and EnEld.